A LEADER in the management of type 2 diabetes and cardiorenal disease.

J Thorac Cardiovasc Surg · 2020

Last updated 2026-05-28

Journal	J Thorac Cardiovasc Surg, 2020
Citations	2
Relative citation ratio	0.05
NIH percentile	5
Molecules	—
Conditions studied	Type 2 Diabetes, Cardiovascular Risk Reduction, Chronic Kidney Disease

Full record and abstract on PubMed 31227180 ↗